Science & Enterprise subscription

Follow us on Twitter

  • A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is ra… https://t.co/LFNVxych8d
    about 5 hours ago
  • New post on Science and Enterprise: New Allergy Biotech Launches, Raises $10M https://t.co/x5W0TwnCBu #Science #Business
    about 5 hours ago
  • Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 inf… https://t.co/LaUrUiRmhk
    about 1 day ago
  • New post on Science and Enterprise: Trial Set for Covid-19 Antibodies in Long-Term Care https://t.co/tF0a7CDgGr #Science #Business
    about 1 day ago
  • The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 a… https://t.co/AO2DxxTgF8
    about 1 day ago

Please share Science & Enterprise

New Allergy Biotech Launches, Raises $10M

Peanutes in shells

A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round. . . . → Read More: New Allergy Biotech Launches, Raises $10M

Trial Set for Covid-19 Antibodies in Long-Term Care

Mobile lab team

Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care. . . . → Read More: Trial Set for Covid-19 Antibodies in Long-Term Care

Covid-19 Vaccines, Therapies – 3 August 2020

Vaccine and therapy tracker

The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 and 35 respectively. . . . → Read More: Covid-19 Vaccines, Therapies – 3 August 2020

NIH Issues Contracts for Faster Covid-19 Diagnostics

Accula SARS-CoV-2 test

National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays. . . . → Read More: NIH Issues Contracts for Faster Covid-19 Diagnostics

A.I. Employed for Local Covid-19 Prediction Models

Network illustration

Computer scientists in California are writing deep learning algorithms that generate forecasts for Covid-19 infections in local communities. . . . → Read More: A.I. Employed for Local Covid-19 Prediction Models

Two Covid-19 Vaccines Show Preclinical Immune Responses

SARS-Cov-2 viruses

Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks. . . . → Read More: Two Covid-19 Vaccines Show Preclinical Immune Responses

Trial Underway for Seasonal Flu Antibody Therapy

Cattle

A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza. . . . → Read More: Trial Underway for Seasonal Flu Antibody Therapy

Sensor Patch Captures Health Indicators in Sweat

Runner silhouettes

A bio-engineering lab created a wearable fabric patch with threads configured into sensors that capture and measure health indicators from human sweat. . . . → Read More: Sensor Patch Captures Health Indicators in Sweat

Neuro Disease Start-Up Raises $73M in Early Funds

Neuron

A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds

Trial Testing Lymphoma Drug to Treat Covid-19

SARS-Cov-2 virus

A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections. . . . → Read More: Trial Testing Lymphoma Drug to Treat Covid-19